Gapping up
In reaction to earnings/guidance:
In reaction to earnings/guidance:
- CFB +7.4%, METC +5.8% (guidance), JNJ +1.7%, BK +1%, BAC +1%
Other news:
- GLUE +25% (announces strategic collaboration with Roche (RHHBY) to discover novel molecular glue degraders targeting cancer and neurological diseases)
- WH +14.9% (Wyndham Hotels & Resorts receives proposal to be acquired by Choice Hotels (CHH) for $90.00 per share)
- CDNA +3.5% (Presents New Data at the American Society for Histocompatibility and Immunogenetics Annual Meeting)
- CLVT +1.7% (Impactive Capital discloses 5.3% passive stake)
- MRO +0.9% (five-year LNG sales agreement with Glencore)
Analyst comments:
- HASI +4.6% (upgraded to Overweight from Equal-Weight at Morgan Stanley)
- ARRY +3.4% (upgraded to Equal-Weight from Underweight at Morgan Stanley)
- OLLI +2.4% (upgraded to Buy from Neutral at Goldman)
- DLTR +2.2% (upgraded to Buy from Neutral at Goldman)
- SXT +1.2% (upgraded to Outperform from Neutral at Robert Baird)
- NBR +1.1% (upgraded to Overweight from Equal-Weight at Morgan Stanley)